|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan AC, Cheung TT, Fan ST, Chok KS, Chan
SC, Poon RT and Lo CM: Survival analysis of high-intensity focused
ultrasound therapy versus radiofrequency ablation in the treatment
of recurrent hepatocellular carcinoma. Ann Surg. 257:686–692. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jarnagin WR, Weber S, Tickoo SK, Koea JB,
Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH and Klimstra D:
Combined hepatocellular and cholangio-carcinoma: Demographic,
clinical and prognostic factors. Cancer. 94:2040–2046. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang D, Nagano H, Nakamura M, Wada H,
Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K and Monden M:
Clinical and pathological eatures of Allen's type C classification
of resected combined hepatocellular and cholangiocarcinoma: A
comparative study with hepatocellular carcinoma and
cholangiocellular carcinoma. J Gastrointest Surg. 10:987–998. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goodman ZD, Ishak KG, Langloss JM,
Sesterhenn IA and Rabin L: Combined
hepatocellular-cholangiocarcinoma. A histologic and
immunohistochemical study. Cancer. 55:124–135. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kassahun WT and Hauss J: Management of
combined hepatocellular and cholangiocarcinoma. Int J Clin Pract.
62:1271–12782008. View Article : Google Scholar
|
|
7
|
Kim KH, Lee SG, Park EH, et al: Surgical
treatments and prognoses of patients with combined hepatocellular
carcinoma and cholangiocarcinoma. Ann Surg Oncol. 2009.16(3):
623–629. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Allen RA and Lisa JR: Combined liver cell
and bile duct carcinoma. Am J Pathol. 25:647–655. 1949.PubMed/NCBI
|
|
9
|
Yano Y, Yamamoto J, Kosuge T, Sakamoto Y,
Yamasaki S, Shimada K, Ojima H, Sakamoto M, Takayama T and Makuuchi
M: Combined hepatocellular and cholangiocarcinoma: a
clinicopathologic study of 26 resected cases. Jpn J Clin Oncol.
33:283–287. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao J, Huang L, Liu C, Li J, Zhang X, Shen
J, Li J, Lu L, Xu F, Yan J, Wu M, Lau WY and Yan Y: Double primary
hepatic cancer hepatocellular carcinoma and intrahepatic
cholangiocarcinoma) in a single patient: A clinicopathologic study
of 35 resected cases. J Gastroenterol Hepatol. 28:1025–1031. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Everhart JE, Wright EC, Goodman ZD,
Dienstag JL, Hoefs JC, Kleiner DE, Ghany MG, Mills AS, Nash SR,
Govindarajan S, et al: HALT-C Trial Group: Prognostic value of
Ishak fibrosis stage: Findings from the hepatitis C antiviral
long-term treatment against cirrhosis trial. Hepatology.
51:585–594. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maganty K, Levi D, Moon J, Bejarano PA,
Arosemena L, Tzakis A and Martin P: Combined hepatocellular
carcinoma and intrahepatic cholangiocarcinoma: Outcome after liver
transplantation. Dig Dis Sci. 55:3597–3601. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Franssen B, Alshebeeb K, Tabrizian P,
Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S and Schwartz
ME: Differences in surgical outcomes between hepatitis B- and
hepatitis C-related hepatocellular carcinoma: A retrospective
analysis of a single North American center. Ann Surg. 260:650–656.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shaib YH, El-Serag HB, Davila JA, Morgan R
and McGlynn KA: Risk factors of intrahepatic cholangiocarcinoma in
the United States: A case-control study. Gastroenterology.
128:620–626. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mant D and Primrose J: CEA monitoring in
colorectal cancer is not a waste of time. BMJ. 18:3482014.
|
|
16
|
Shim JH, Yoon DL, Han S, Lee YJ, Lee SG,
Kim KM, Lim YS, Lee HC, Chung YH and Lee YS: Is serum
alpha-fetoprotein useful for predicting recurrence and mortality
specific to hepatocellular carcinoma after hepatectomy? A test
based on propensity scores and competing risks analysis. Ann Surg
Oncol. 19:3687–3696. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jeng KS, Sheen IS, Jeng WJ, Yu MC, Hsiau
HI, Chang FY and Tsai HH: Activation of the sonic hedgehog
signaling pathway occurs in the CD133 positive cells of mouse liver
cancer Hepa 1–6 cells. Onco Targets Ther. 6:1047–1055. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Massani M, Stecca T, Fabris L, Caratozzolo
E, Ruffolo C, Furlanetto A, Morton S, Cadamuro M, Strazzabosco M
and Bassi N: Isolation and characterization of biliary epithelial
and stromal cells from resected human cholangiocarcinoma: A novel
in vitro model to study tumor-stroma interactions. Oncol Rep.
30:1143–1148. 2013.PubMed/NCBI
|
|
19
|
Moritoki Y, Ueno Y, Kanno N, Yamagiwa Y,
Fukushima K, Gershwin ME and Shimosegawa T: Amniotic epithelial
cell-derived cholangiocytes in experimental cholestatic ductal
hyperplasia. Hepatol Res. 37:286–294. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu J, Sasaki M, Harada K, Sato Y, Ikeda H,
Kim JH, Yu E and Nakanuma Y: Intrahepatic cholangiocarcinoma
arising in chronic advanced liver disease and the
cholangiocarcinomatous component of hepatocellular
cholangiocarcinoma share common phenotypes and
cholangiocarcinogenesis. Histopathol. 59:1090–1099. 2011.
View Article : Google Scholar
|
|
21
|
Stuntz R, Kochert E, Kehrl T and Schrading
W: The effect of sonologist experience on the ability to determine
endotracheal tube location using transtracheal ultrasound. Am J
Emerg Med. 32:267–269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim TK, Jang HJ and Wilson SR: Imaging
diagnosis of hepatocellular carcinoma with differentiation from
other pathology. Clin Liver Dis. 9:253–279. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wagner K, Peters M, Scholz A, Benckert C,
Ruderisch HS, Wiedenmann B and Rosewicz S: Activin A stimulates
vascular endothelial growth factor gene transcription in human
hepatocellular carcinoma cells. Gastroenterology. 126:1828–1843.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang Y, Lee JM, Kim SH, Han JK and Choi
BI: Intrahepatic mass-forming cholangiocarcinoma: Enhancement
patterns on gadoxetic acid-enhanced MR images. Radiology.
264:751–760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amini N, Ejaz A, Spolverato G, Maithel SK,
Kim Y and Pawlik TM: Management of lymph nodes during resection of
hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A
systematic review. J Gastrointest Surg. 18:2136–2148. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Popescu I and Dumitrascu T:
Curative-intent surgery for hilar cholangiocarcinoma: Prognostic
factors for clinical decision making. Langenbecks Arch Surg.
399:693–705. 2014. View Article : Google Scholar : PubMed/NCBI
|
